167 related articles for article (PubMed ID: 20231324)
1. A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence.
Pettinati HM; Oslin DW; Kampman KM; Dundon WD; Xie H; Gallis TL; Dackis CA; O'Brien CP
Am J Psychiatry; 2010 Jun; 167(6):668-75. PubMed ID: 20231324
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, placebo-controlled study of sertraline with naltrexone for alcohol dependence.
Farren CK; Scimeca M; Wu R; Malley SO
Drug Alcohol Depend; 2009 Jan; 99(1-3):317-21. PubMed ID: 18644685
[TBL] [Abstract][Full Text] [Related]
3. Treatment of late-life depression complicated by alcohol dependence.
Oslin DW
Am J Geriatr Psychiatry; 2005 Jun; 13(6):491-500. PubMed ID: 15956269
[TBL] [Abstract][Full Text] [Related]
4. The effects of sertraline on psychopathic traits.
Dunlop BW; DeFife JA; Marx L; Garlow SJ; Nemeroff CB; Lilienfeld SO
Int Clin Psychopharmacol; 2011 Nov; 26(6):329-37. PubMed ID: 21909028
[TBL] [Abstract][Full Text] [Related]
5. Association of platelet function with depression and its treatment with sertraline in patients with chronic kidney disease: analysis of a randomized trial.
Jain N; Wan F; Kothari M; Adelodun A; Ware J; Sarode R; Hedayati SS
BMC Nephrol; 2019 Oct; 20(1):395. PubMed ID: 31664940
[TBL] [Abstract][Full Text] [Related]
6. Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence.
Petrakis IL; Ralevski E; Desai N; Trevisan L; Gueorguieva R; Rounsaville B; Krystal JH
Neuropsychopharmacology; 2012 Mar; 37(4):996-1004. PubMed ID: 22089316
[TBL] [Abstract][Full Text] [Related]
7. Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence.
Pettinati HM; Kampman KM; Lynch KG; Suh JJ; Dackis CA; Oslin DW; O'Brien CP
J Subst Abuse Treat; 2008 Jun; 34(4):378-90. PubMed ID: 17664051
[TBL] [Abstract][Full Text] [Related]
8. Moderate Alcohol Consumption Increases the Risk of Clinical Relapse in Male Depressed Patients Treated with Serotonin-Norepinephrine Reuptake Inhibitors.
Mușat MI; Militaru F; Gheorman V; Udriștoiu I; Mitran SI; Cătălin B
Diagnostics (Basel); 2024 May; 14(11):. PubMed ID: 38893667
[TBL] [Abstract][Full Text] [Related]
9. The Association between Alcohol Dependence and Depression before and after Treatment for Alcohol Dependence.
Kuria MW; Ndetei DM; Obot IS; Khasakhala LI; Bagaka BM; Mbugua MN; Kamau J
ISRN Psychiatry; 2012; 2012():482802. PubMed ID: 23738204
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial of combined citalopram and naltrexone for nonabstinent outpatients with co-occurring alcohol dependence and major depression.
Adamson SJ; Sellman JD; Foulds JA; Frampton CM; Deering D; Dunn A; Berks J; Nixon L; Cape G
J Clin Psychopharmacol; 2015 Apr; 35(2):143-9. PubMed ID: 25679122
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
[TBL] [Abstract][Full Text] [Related]
12. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial.
Foa EB; Yusko DA; McLean CP; Suvak MK; Bux DA; Oslin D; O'Brien CP; Imms P; Riggs DS; Volpicelli J
JAMA; 2013 Aug; 310(5):488-95. PubMed ID: 23925619
[TBL] [Abstract][Full Text] [Related]
13. Combining sertraline and naltrexone in the treatment of adults with comorbid depression and alcohol dependence.
Balaratnasingam S; Janca A
Curr Psychiatry Rep; 2011 Aug; 13(4):245-7. PubMed ID: 21468673
[No Abstract] [Full Text] [Related]
14. Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial.
Hser YI; Saxon AJ; Huang D; Hasson A; Thomas C; Hillhouse M; Jacobs P; Teruya C; McLaughlin P; Wiest K; Cohen A; Ling W
Addiction; 2014 Jan; 109(1):79-87. PubMed ID: 23961726
[TBL] [Abstract][Full Text] [Related]
15. Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START).
Potter JS; Marino EN; Hillhouse MP; Nielsen S; Wiest K; Canamar CP; Martin JA; Ang A; Baker R; Saxon AJ; Ling W
J Stud Alcohol Drugs; 2013 Jul; 74(4):605-13. PubMed ID: 23739025
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression.
Mason BJ; Kocsis JH; Ritvo EC; Cutler RB
JAMA; 1996 Mar; 275(10):761-7. PubMed ID: 8598592
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive aripiprazole therapy with escitalopram in patients with co-morbid major depressive disorder and alcohol dependence: clinical and neuroimaging evidence.
Han DH; Kim SM; Choi JE; Min KJ; Renshaw PF
J Psychopharmacol; 2013 Mar; 27(3):282-91. PubMed ID: 23325372
[TBL] [Abstract][Full Text] [Related]
18. Mirtazapine in Comorbid Major Depression and Alcohol Dependence: An Open-Label Trial.
Cornelius JR; Douaihy AB; Clark DB; Chung T; Wood DS; Daley D
J Dual Diagn; 2012 Sep; 8(3):200-204. PubMed ID: 23230395
[TBL] [Abstract][Full Text] [Related]
19. Current status of co-occurring mood and substance use disorders: a new therapeutic target.
Pettinati HM; O'Brien CP; Dundon WD
Am J Psychiatry; 2013 Jan; 170(1):23-30. PubMed ID: 23223834
[TBL] [Abstract][Full Text] [Related]
20. Impact of depressive symptoms on future alcohol use in patients with co-occurring bipolar disorder and alcohol dependence: a prospective analysis in an 8-week randomized controlled trial of acamprosate.
Prisciandaro JJ; DeSantis SM; Chiuzan C; Brown DG; Brady KT; Tolliver BK
Alcohol Clin Exp Res; 2012 Mar; 36(3):490-6. PubMed ID: 21933201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
